Hemodynamic factors and indirect assessment of myocardial oxygen consumption in the therapy of angina pectoris.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000787:Angina Pectoris / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D001794:Blood Pressure / Q000187:drug effects; D001026:Coronary Artery Bypass; D003326:Coronary Circulation / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009566:Nitrates / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010806:Physical Education and Training
D000319:Adrenergic beta-Antagonists; D009566:Nitrates; D005996:Nitroglycerin